Rep. Jake Auchincloss (D-Mass.), an influential voice in Congress on life sciences issues, gained stature last week when he was appointed to serve on the Energy & Commerce Committee, giving him a seat at the table for debates over legislation affecting FDA, CMS and NIH and a host of issues of critical importance to the biopharma industry.
In an interview with Washington Editor Steve Usdin on The BioCentury Show, Auchincloss outlined his priorities for the 119th Congress, from pushing “muscular” PBM reform over the congressional finish line to finding bipartisan support for refining the IRA's orphan drug exemption and advancing methods to evaluate the social value of medicines.
View full story: https://www.biocentury.com/article/654659
#biotech #biopharma #pharma #lifescience #politics #policy #law
00:00 - Introduction
01:08 - New Congress & RFK Jr.
10:09 - China & Biotech
16:36 - Assessing Drugs’ Value